Manual morcellation compared to power morcellation during robotic myomectomy

Area of Science:

• Gynecology
• Minimally Invasive Surgery
• Surgical Technology

Background:

• The 2014 U.S. Food and Drug Administration (FDA) warning impacted clinical practices for hysterectomy and myomectomy.
• There is limited data on contained manual morcellation techniques as alternatives to power morcellation.
• Robotic myomectomy is a common procedure where tissue extraction methods are critical.

Purpose of the Study:

• To compare perioperative outcomes of contained manual morcellation versus power morcellation in robotic myomectomy.
• To evaluate the safety and efficacy of contained manual morcellation.
• To identify factors influencing surgical time in robotic myomectomy.

Main Methods:

• Retrospective analysis of women undergoing robotic myomectomy with either contained manual morcellation (n=38) or power morcellation (n=62).
• Comparison of operative time, patient demographics, specimen characteristics, blood loss, and post-operative pain management.
• Linear regression modeling to identify predictors of surgical time.

Main Results:

• Contained manual morcellation was associated with a significant decrease in mean operative time (105.4 min vs. 126.1 min, p=0.02).
• Patient demographics, specimen weight, estimated blood loss, and post-operative narcotic use were similar between groups.
• Same-day discharge rates were comparable (86% vs. 90%, p=0.74).
• Specimen weight, number of fibroids, and use of power morcellation were significant predictors of surgical time.

Conclusions:

• Contained manual morcellation is a viable alternative to power morcellation during robotic myomectomy, leading to reduced surgical time.
• The technique demonstrates similar safety profiles regarding blood loss and post-operative recovery.
• Further investigation into contained manual morcellation can refine surgical practices post-FDA warning.